Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products



Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products
The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

Leave a Reply

Your email address will not be published. Required fields are marked *